PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $601,000 | -42.4% | 72,097 | -8.0% | 0.00% | -50.0% |
Q2 2023 | $1,043,000 | +0.1% | 78,341 | -12.9% | 0.00% | 0.0% |
Q1 2023 | $1,042,000 | +47.2% | 89,906 | +3.7% | 0.00% | 0.0% |
Q4 2022 | $708,000 | +12.4% | 86,723 | -19.8% | 0.00% | 0.0% |
Q3 2022 | $630,000 | -10.4% | 108,138 | -32.6% | 0.00% | 0.0% |
Q2 2022 | $703,000 | -63.0% | 160,423 | -23.1% | 0.00% | -50.0% |
Q1 2022 | $1,902,000 | +2.1% | 208,665 | +129.6% | 0.00% | 0.0% |
Q4 2021 | $1,862,000 | -10.3% | 90,885 | +11.9% | 0.00% | -33.3% |
Q3 2021 | $2,076,000 | -28.0% | 81,239 | -1.6% | 0.01% | -25.0% |
Q2 2021 | $2,885,000 | -7.5% | 82,560 | -11.1% | 0.01% | -20.0% |
Q1 2021 | $3,119,000 | +740.7% | 92,833 | +549.2% | 0.01% | +400.0% |
Q4 2020 | $371,000 | +267.3% | 14,300 | -48.5% | 0.00% | +100.0% |
Q2 2017 | $101,000 | +7.4% | 27,785 | +35.1% | 0.00% | 0.0% |
Q1 2017 | $94,000 | – | 20,560 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madrone Advisors, LLC | 16,415,933 | $137,073,041 | 29.47% |
ORACLE INVESTMENT MANAGEMENT INC | 1,638,395 | $13,680,598 | 4.20% |
Decheng Capital Management III (Cayman), LLC | 1,463,872 | $12,223,331 | 4.08% |
VK Services, LLC | 2,632,784 | $21,983,746 | 2.93% |
Iron Triangle Partners LP | 1,800,000 | $15,030,000 | 2.20% |
BOURNE LENT ASSET MANAGEMENT INC | 574,350 | $4,795,822 | 2.11% |
Deep Track Capital, LP | 6,000,000 | $50,100,000 | 1.93% |
Jackson Square Partners, LLC | 6,933,865 | $57,897,773 | 1.93% |
ARK Investment Management | 29,822,440 | $249,017,370 | 1.90% |
Nikko Asset Management Americas, Inc. | 13,447,666 | $112,153,534 | 1.34% |